| Entry |
|
|---|
| Name |
Vidarabine (JAN);
Vidarabine anhydrous;
ARA-A;
Armes (TN) |
|---|
| Formula |
C10H13N5O4
|
|---|
| Exact mass |
267.0968
|
|---|
| Mol weight |
267.24
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01440 Arabinofuranosyl type antiviral
DG02840 Anti-herpesvirus agent
|
|---|
| Remark |
| Therapeutic category: | 6250 |
| Product (DG00645): | D06298<JP> |
|
|---|
| Efficacy |
Antiviral, DNA polymerase inhibitor |
|---|
| Comment |
Arabinofuranosyl derivative
|
|---|
| Target |
Herpesvirus DNA polymerase [KO: K18964] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07041 | Antineoplastics - antimetabolic agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB03 Vidarabine
D06298 Vidarabine (JAN) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD06 Vidarabine
D06298 Vidarabine (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D06298 Vidarabine (JAN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
91 Antivirals
D06298 Vidarabine (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Vidarabine
D06298 Vidarabine (JAN)
Drug groups [BR:br08330]
Antiviral
DG01440 Arabinofuranosyl type antiviral
DG00645 Vidarabine
D06298 Vidarabine
DG02840 Anti-herpesvirus agent
DG00645 Vidarabine
D06298 Vidarabine
Drug classes [BR:br08332]
Antiviral
DG02840 Anti-herpesvirus agent
D06298 Vidarabine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
D06298 Vidarabine (JAN) <JP>
Rx-to-OTC switch list in Japan [br08314.html]
D06298
Drug groups [BR:br08330]
Antiviral
DG01440 Arabinofuranosyl type antiviral
DG00645 Vidarabine
DG02840 Anti-herpesvirus agent
DG00645 Vidarabine
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
DG00645 Vidarabine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 N4y N 24.4593 -17.9096
2 C8y C 25.5947 -18.7423
3 C1y C 23.1374 -18.3465
4 C8x C 24.8960 -16.5880
5 C8y C 26.7243 -17.9213
6 N5x N 25.7286 -20.1282
7 O2x O 22.0020 -17.5196
8 C1y C 22.6949 -19.6798
9 N5x N 26.2992 -16.5880
10 C8y C 27.9995 -18.4978
11 C8x C 27.0039 -20.6989
12 C1y C 20.8606 -18.3465
13 C1y C 21.2972 -19.6798
14 O1a O 23.5218 -20.8095
15 N5x N 28.1393 -19.8896
16 N1a N 29.1409 -17.6768
17 C1b C 19.5272 -17.9096
18 O1a O 20.4762 -20.8095
19 O1a O 18.4907 -18.8531
BOND 21
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 8 14 1 #Up
14 10 15 2
15 10 16 1
16 12 17 1 #Up
17 13 18 1 #Down
18 17 19 1
19 5 9 1
20 11 15 1
21 12 13 1
|
|---|
